Evaluation of the effect of lemon balm plant on primary blood pressure control

The explanation of the causes of high blood pressure and its therapies in Persian medicine and the effect of Lemongrass herbal product in primary blood pressure control

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170820035796N2

Enrollment

Registered

2019-01-08

Start date

2018-10-23

Completion date

Unknown

Last updated

2019-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group: Miliotropic capsule containing 400 mg of lemon balm daily three times a day for 4 weeks. Intervention 2: Control group: The capsule contains 400 mg of lactose daily

Eligibility

Sex/Gender

All

Age

30 Years to 75 Years

Inclusion criteria

Inclusion criteria: Men and women 30-75 years old ??Systolic blood pressure greater than or equal to 140, and diastolic blood pressure greater than or equal to 90 mmHg being treated with blood pressure medication (one to three drugs based on the protocol), but the patient’s blood pressure is uncontrolled At least one month has elapsed since the onset of drug use Have informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: Blood pressure equal to or greater than 110/180 at the start of the study or during intervention History of secondary hypertension Major symptoms of major organ damage (such as renal failure, congestive heart failure, myocardial infarction, or cerebrovascular accidents) During the 6 months before the study The presence of any type of cardiac arrhythmia (such as second- or third-degree blocks) Symptomatic valvular disease Liver dysfunction Type 1 and type 2 diabetic patients with impaired renal and liver function to the extent that clinically significant (ie more than 1.5 times the maximum normal creatinine and alanine aminotransferase more than 3 times the normal maximum) Low platelet count More than 100,000 per microliter of blood History of treated or untreated malignancies Potassium greater than 1.5 or less than 3.5 mg / L in the first visit History of hypothyroidism or hyperthyroidism Pregnancy and lactation The presence of any medical or surgical disorder that could interfere with the study.

Design outcomes

Primary

Measure	Time frame
Blood pressure. Timepoint: In baseline and 5 times follow up measurement every 2 weeks. Method of measurement: Sphygmomanometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyde Sedighe Yousefi

Sari University of Medical Sciences

z.shekarriz@mazums.ac.ir+98 11 3324 4893

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026